Atlas FDA

PhasTIPP

FDA 510(k) clearance K212894 · decided 2022-03-31

Clearance details

K-number
K212894
Device name
PhasTIPP
Applicant
LeMaitre Vascular, Inc.
Decision
Substantially Equivalent
Date received
2021-09-10
Decision date
2022-03-31
Days to decision
202 days
Clearance type
Traditional
Product code
DWQ
Device class
2
Regulation number
870.4885
Medical specialty
Cardiovascular
Advisory committee
Cardiovascular
Location
Burlington, MA, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch LeMaitre Vascular

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
SMITH & NEPHEW TUMESCENT CATHETER INVERSION SYSTEM, MODEL 7210023 (K041453)Smith & Nephew, Inc.2004-07-22
TRIVEX SYSTEM (K032387)Smith & Nephew, Inc.2003-10-29
URESIL VALVE CUTTER (K905528)Uresil Corp.1991-04-18
PILLING BRUSH VALVULOTOME (K904507)Pilling Co.1991-03-01
INSITUCAT VALVE STRIPPER (K885046)Aesculap Instruments Corp.1990-02-28
HALL VEIN STRIPPER (K872157)Solco Basle, Inc.1987-07-07
VEIN-TRAP TM (K811910)Atrium Medical Corp.1981-07-20

Recalls involving this device

No recalls on record reference this clearance.

PMA approvals by this applicant

RecordFirmDate
Artegraft Collagen Vascular Graft (N16837/S036)LeMaitre Vascular, Inc.2025-06-11
Artegraft Collagen Vascular Graft (N16837/S035)LeMaitre Vascular, Inc.2024-12-18
Artegraft Collagen Vascular Graft (N16837/S034)LeMaitre Vascular, Inc.2024-10-17
Artegraft Collagen Vascular Graft (N16837/S033)LeMaitre Vascular, Inc.2024-05-02
Artegraft Collagen Vascular Graft (N16837/S032)LeMaitre Vascular, Inc.2023-09-19
Artegraft Collagen Vascular Graft (N16837/S031)LeMaitre Vascular, Inc.2023-06-29
Artegraft Collagen Vascular Graft (N16837/S030)LeMaitre Vascular, Inc.2023-04-25
Artegraft Collagen Vascular Graft (N16837/S029)LeMaitre Vascular, Inc.2023-01-25